AB THERAPY: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AB THERAPY
Largest movements
- Cash +€24,255
up €24,255 (+71.8%), from €33,766 to €58,021
mainly Other debts (+€31,450) and Net result for the year (+€26,173)
- Other debts +€31,450
new in 2025: €31,450
- Profit (loss) carried forward -€10,827
down €10,827 (-14.3%), from €75,448 to €64,622
- Tax, wage and social debts +€5,550
new in 2025: €5,550
- Taxes +€6,452
up €6,452 (+199.2%), from €3,238 to €9,690
- Gross operating margin -€4,091
down €4,091 (-8.5%), from €47,971 to €43,880
- Staff costs +€880
up €880 (+71.4%), from €1,232 to €2,112
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €80,015 | €106,347 | +€26,332 | +32.9% |
| Fixed assets | 21/28 | €25,085 | €25,337 | +€252 | +1.0% |
| Tangible fixed assets | 22/27 | €22,760 | €23,012 | +€252 | +1.1% |
| Furniture and vehicles | 24 | €4,760 | €8,012 | +€3,252 | +68.3% |
| Other tangible fixed assets | 26 | €18,000 | €15,000 | -€3,000 | -16.7% |
| Financial fixed assets | 28 | €2,325 | €2,325 | = | 0.0% |
| Current assets | 29/58 | €54,930 | €81,010 | +€26,080 | +47.5% |
| Amounts receivable within one year | 40/41 | €20,976 | €21,832 | +€856 | +4.1% |
| Trade receivables | 40 | €14,791 | €12,467 | -€2,325 | -15.7% |
| Other amounts receivable | 41 | €6,185 | €9,365 | +€3,180 | +51.4% |
| Cash at bank and in hand | 54/58 | €33,766 | €58,021 | +€24,255 | +71.8% |
| Deferred charges and accrued income | 490/1 | €188 | €1,157 | +€969 | +514.9% |
| Total equity and liabilities | 10/49 | €80,015 | €106,347 | +€26,332 | +32.9% |
| Equity | 10/15 | €78,448 | €67,622 | -€10,827 | -13.8% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €75,448 | €64,622 | -€10,827 | -14.3% |
| Amounts payable | 17/49 | €1,567 | €38,725 | +€37,158 | +2371.9% |
| Amounts payable after more than one year | 17 | €1,350 | €1,350 | = | 0.0% |
| Other amounts payable | 178/9 | €1,350 | €1,350 | = | 0.0% |
| Amounts payable within one year | 42/48 | €217 | €37,000 | +€36,783 | +16983.0% |
| Trade debts | 44 | €217 | - | -€217 | |
| Suppliers | 440/4 | €217 | - | -€217 | |
| Taxes, remuneration and social security | 45 | - | €5,550 | +€5,550 | |
| Taxes | 450/3 | - | €5,550 | +€5,550 | |
| Other amounts payable | 47/48 | - | €31,450 | +€31,450 | |
| Accrued charges and deferred income | 492/3 | - | €375 | +€375 | |
| Remuneration, social security and pensions | 62 | €1,232 | €2,112 | +€880 | +71.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,664 | €5,496 | -€168 | -3.0% |
| Other operating charges | 640/8 | - | €239 | +€239 | |
| Non-recurring operating charges | 66A | €350 | - | -€350 | |
| Gross operating margin | 9900 | €47,971 | €43,880 | -€4,091 | -8.5% |
| Operating profit (loss) | 9901 | €40,725 | €36,034 | -€4,692 | -11.5% |
| Financial charges | 65/66B | €350 | €170 | -€180 | -51.4% |
| Recurring financial charges | 65 | €350 | €170 | -€180 | -51.4% |
| Profit (loss) for the period before taxes | 9903 | €40,375 | €35,863 | -€4,511 | -11.2% |
| Income taxes | 67/77 | €3,238 | €9,690 | +€6,452 | +199.2% |
| Profit (loss) for the period | 9904 | €37,136 | €26,173 | -€10,963 | -29.5% |
| Profit (loss) for the period to be appropriated | 9905 | €37,136 | €26,173 | -€10,963 | -29.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.